Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3741019015 | Product containing only lanreotide in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3741020014 | Lanreotide only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5568221000241115 | produit contenant seulement du lanréotide sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only lanreotide in parenteral dose form (medicinal product form) | Is a | Product containing only lanreotide (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only lanreotide in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only lanreotide in parenteral dose form (medicinal product form) | Has active ingredient | Lanreotide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only lanreotide in parenteral dose form (medicinal product form) | Is a | Lanreotide-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing only lanreotide in parenteral dose form (medicinal product form) | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial | Is a | True | Product containing only lanreotide in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely lanreotide (as lanreotide acetate) 180 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Product containing only lanreotide in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Lanreotide (as lanreotide acetate) 120 mg/mL solution for injection | Is a | True | Product containing only lanreotide in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Lanreotide (as lanreotide acetate) 240 mg/mL solution for injection | Is a | True | Product containing only lanreotide in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR